At the peak of its game and with no big new product transitions under way, Apple can run perfectly well without Steve Jobs during his planned leave of absence to the end of June.
But the poor health of its iconic leader also raises deeper questions that will leave a dark cloud over its stock price and could start to eat into its longer-term business prospects unless the board acts quickly to resolve the uncertainty.
